Leppä Aino-Maija, Grimes Karen, Jeong Hyobin, Huang Frank Y, Andrades Alvaro, Waclawiczek Alexander, Boch Tobias, Jauch Anna, Renders Simon, Stelmach Patrick, Müller-Tidow Carsten, Karpova Darja, Sohn Markus, Grünschläger Florian, Hasenfeld Patrick, Benito Garagorri Eva, Thiel Vera, Dolnik Anna, Rodriguez-Martin Bernardo, Bullinger Lars, Mrózek Krzysztof, Eisfeld Ann-Kathrin, Krämer Alwin, Sanders Ashley D, Korbel Jan O, Trumpp Andreas
Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
Nat Genet. 2024 Dec;56(12):2790-2803. doi: 10.1038/s41588-024-01999-x. Epub 2024 Nov 25.
Chromosomal instability is a major driver of intratumoral heterogeneity (ITH), promoting tumor progression. In the present study, we combined structural variant discovery and nucleosome occupancy profiling with transcriptomic and immunophenotypic changes in single cells to study ITH in complex karyotype acute myeloid leukemia (CK-AML). We observed complex structural variant landscapes within individual cells of patients with CK-AML characterized by linear and circular breakage-fusion-bridge cycles and chromothripsis. We identified three clonal evolution patterns in diagnosis or salvage CK-AML (monoclonal, linear and branched polyclonal), with 75% harboring multiple subclones that frequently displayed ongoing karyotype remodeling. Using patient-derived xenografts, we demonstrated varied clonal evolution of leukemic stem cells (LSCs) and further dissected subclone-specific drug-response profiles to identify LSC-targeting therapies, including BCL-xL inhibition. In paired longitudinal patient samples, we further revealed genetic evolution and cell-type plasticity as mechanisms of disease progression. By dissecting dynamic genomic, phenotypic and functional complexity of CK-AML, our findings offer clinically relevant avenues for characterizing and targeting disease-driving LSCs.
染色体不稳定性是肿瘤内异质性(ITH)的主要驱动因素,促进肿瘤进展。在本研究中,我们将结构变异发现和核小体占位分析与单细胞中的转录组和免疫表型变化相结合,以研究复杂核型急性髓系白血病(CK-AML)中的ITH。我们在CK-AML患者的单个细胞内观察到复杂的结构变异图谱,其特征为线性和环状的断裂-融合-桥循环以及染色体碎裂。我们在初诊或挽救性CK-AML中确定了三种克隆进化模式(单克隆、线性和分支多克隆),75%的患者具有多个亚克隆,这些亚克隆经常显示出持续的核型重塑。利用患者来源的异种移植,我们证明了白血病干细胞(LSC)的不同克隆进化,并进一步剖析了亚克隆特异性药物反应谱,以确定靶向LSC的疗法,包括抑制BCL-xL。在配对的纵向患者样本中,我们进一步揭示了基因进化和细胞类型可塑性是疾病进展的机制。通过剖析CK-AML的动态基因组、表型和功能复杂性,我们的研究结果为表征和靶向驱动疾病的LSC提供了临床相关途径。